Susquehanna International Group
IPCI

Susquehanna International Group’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Susquehanna International Group’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,210
Closed -$30K – 10214
2017
Q1 		$30K Buy
+1,210
New +$31.2K ﹤0.01% 8671
2015
Q1 		– Sell
-1,410
Closed -$32K – 10228
2014
Q4 		$32K Buy
+1,410
New +$38.1K ﹤0.01% 9444

Other funds holding IPCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
FANJ
Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Susquehanna International Group's IPCI Position: Q3 2018 in Review

Susquehanna International Group sold out of Intellipharmaceuticals International Inc. (IPCI) in Q3 2018, closing a stake of 1,550 shares — an estimated $7K sold.

Susquehanna International Group first reported a position in IPCI in Q2 2014 and held it in 14 quarters. The position peaked at $301K in Q2 2017. 10 funds tracked by Wall St. Rank hold IPCI as of Q3 2018.

  • Susquehanna International Group reported no remaining Intellipharmaceuticals International Inc. position as of Q3 2018 after selling out during the quarter.
  • Susquehanna International Group sold 1,550 Intellipharmaceuticals International Inc. shares in Q3 2018, an estimated $7K.
  • Susquehanna International Group first reported a position in Intellipharmaceuticals International Inc. in Q2 2014 and held it in 14 quarters.
  • Susquehanna International Group's Intellipharmaceuticals International Inc. position peaked at $301K in Q2 2017.
  • 10 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q3 2018.

Based on Susquehanna International Group's 13F filing for Q3 2018, filed 14 Nov 2018.